Nobel Laureate Jennifer Doudna on Gene Editing and the Future of CRISPR

QBI presents a Twitter Space (live audio conversation) with Jennifer Doudna, Nobel Laureate, co-inventor of CRISPR-Cas9, professor of cellular molecular pharmacology at UCSF, and biochemist at the University of California, Berkeley. Doudna received her PhD in biological chemistry and molecular pharmacology from Harvard Medical School in 1989. She completed her postdoctoral studies at the University of Colorado and then joined the Yale faculty in 1994. In 2002, she accepted a position at Berkeley as a professor of biochemistry and molecular biology. Doudna began studying CRISPR in 2006, leading her to make her 2020 Nobel-Prize-winning discovery using CRISPR-Cas9 with French microbiologist Emmanuelle Charpentier.

The Twitter Space interview on September 27 at 1:30 p.m. Pacific focuses on gene editing and the future of CRISPR technologies. Doudna will address topics related to how technology like CRISPR is rapidly increasing the rate of discovery, what we still don’t know about the genome, how CRISPR can help uncover these mysteries, and how CRISPR may start to appear in your daily life. She will also address common concerns surrounding gene editing technology and continuing to grapple with the ethical responsibility of using CRISPR. Doudna will be interviewed by Jason Gestwicki, professor of pharmaceutical chemistry at UCSF.